Clinical Development and Operations
In 2022, the Clinical Development and Clinical Operations tracks have been combined in order to ensure consistency throughout the content development and avoid any overlapping or duplication.
This comprehensive track will cover evolution in clinical operations, data management, interacting with regulators, patient engagement and other important learnings from the past and the latest advances in clinical research.
Who is This Track Designed For?
DIA recommends this track and associated sessions to professionals involved in research and development, evidence generation, protocol development, study design, biomarker development, project management, patient centricity, statistics, clinical regulatory professionals and clinical assessors, clinical operations, and statistics, medical affairs, clinical quality assurance, regulatory affairs, vendor and alliance management and data management. Also for clinical reviewers, clinical research associates, study managers, patient recruitment professionals.
The online program is now available. Explore the rich content we offer across 10 thought leadership tracks.
Manuel Haas, PharmD, MSc
Executive Director - Regulatory Affairs Europe
MSD, United Kingdom
Rebecca Stanbrook, RPh
Executive Director, Regulatory and Development Policy, Regulatory Affairs
Senior Director, Clinical Lead, Tau, Neurology Patient Value Unit
UCB Biopharma, Belgium
DIA Europe 2022 Highlights
It will provide updates on key developments on the GCP Renovation (ICH E6, ICH E8), Clinical Trial Regulation, the Clinical Trial Information System, data submission, transparency, navigating ethical approval, study design in the digital age, innovative clinical trial designs (umbrella and platform trials, patient centricity), digital tools in development and other hot topics. It should be a must-attend for optimising development programmes and identifying cost savings through efficiency and innovation.